Vedana Therapeutics has raised $46 Million in new Series A funding
According to filings with the U.S. Securities and Exchange Commission, Vedana Therapeutics has raised $46,000,000.00 in new Series A funding. The federal securities law requires the notice to be filed by companies that have sold…